Evidence map›Paper›PMID 30895737›Full record

ArticleCNS neuroscience & therapeutics2019

The absence of NIPA2 enhances neural excitability through BK (big potassium) channels.

Na-Na Liu, Han Xie, Wen-Shu Xiang-Wei, Kai Gao, Tian-Shuang Wang, Yu-Wu Jiang

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Na-Na LiuDepartment of Pediatrics, Peking University First Hospital, Beijing, China.ORCID 0000-0002-0135-3575
Han XieDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Wen-Shu Xiang-WeiDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Kai GaoDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Tian-Shuang WangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Yu-Wu JiangDepartment of Pediatrics, Peking University First Hospital, Beijing, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo reveal the pathogenesis and find the precision treatment for the childhood absence epilepsy (CAE) patients with NIPA2 mutations.

methodsWe performed whole-cell patch-clamp recordings to measure the electrophysiological properties of layer V neocortical somatosensory pyramidal neurons in wild-type (WT) and NIPA2-knockout mice.

resultsWe identified that layer V neocortical somatosensory pyramidal neurons isolated from the NIPA2-knockout mice displayed higher frequency of spontaneous and evoked action potential, broader half-width of evoked action potential, and smaller currents of BK channels than those from the WT mice. NS11021, a specific BK channel opener, reduced neuronal excitability in the NIPA2-knockout mice. Paxilline, a selective BK channel blocker, treated WT neurons and could simulate the situation of NIPA2-knockout group, thereby suggesting that the absence of NIPA2 enhanced the excitability of neocortical somatosensory pyramidal neurons by decreasing the currents of BK channels. Zonisamide, an anti-epilepsy drug, reduced action potential firing in NIPA2-knockout mice through increasing BK channel currents.

conclusionThe results indicate that the absence of NIPA2 enhances neural excitability through BK channels. Zonisamide is probably a potential treatment for NIPA2 mutation-induced epilepsy, which may provide a basis for the development of new treatment strategies for epilepsy.

Indexed as

Action PotentialsAnimalsCation Transport ProteinsEpilepsy, AbsenceFemaleLarge-Conductance Calcium-Activated Potassium ChannelsMaleMiceMice, Inbred C57BLNeocortexPyramidal CellsZonisamideCation Transport ProteinsLarge-Conductance Calcium-Activated Potassium ChannelsNIPA2 protein, mouseZonisamideBK channelsepilepsyneural excitabilityNIPA2zonisamide

Identifiers

PMID30895737
PMCPMC6630003
OpenAlexW2923740290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.